Programming document 2020-22

The Programming Document 2020-22 translates the long-term priorities defined by the EMCDDA Strategy 2025 into short-term operational priorities. The year 2020 marks the end of the first strategic roadmap and the beginning of the second one (towards 2025) and is a time for mid-term assessment and reflection on the way ahead. Main activities include the continuation of two projects aimed at partnership with third countries – the Instrument for Pre-accession Assistance Project 7 and the EU4Monitoring Drugs project – the release of a reshaped European Drug Report and the ESPAD report, as well as the ongoing delivery of value to our stakeholders. We will also be celebrating ’25 years of drug monitoring’ and consolidating our position as the leading European source of information on drugs.